These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 23093586)

  • 1. Rescue reversal: an addendum.
    Kopman AF; Kurata J
    Anesth Analg; 2012 Nov; 115(5):1254-5. PubMed ID: 23093586
    [No Abstract]   [Full Text] [Related]  

  • 2. Reversal of neuromuscular blockade with sugammadex in patients with myasthenia gravis: a case series of 21 patients and review of the literature.
    de Boer HD; Shields MO; Booij LH
    Eur J Anaesthesiol; 2014 Dec; 31(12):715-21. PubMed ID: 25192270
    [No Abstract]   [Full Text] [Related]  

  • 3. Delayed recurarisation after sugammadex reversal.
    Bellod A; March X; Hernandez C; Villalonga A
    Eur J Anaesthesiol; 2014 Dec; 31(12):710-2. PubMed ID: 25101712
    [No Abstract]   [Full Text] [Related]  

  • 4. A novel approach to reversal of neuromuscular blockade.
    Della Rocca G; Pompei L
    Minerva Anestesiol; 2009 May; 75(5):349-51. PubMed ID: 19412157
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Can residual paralysis be avoided?: A critical appraisal of the use of sugammadex.
    Esteves S
    Eur J Anaesthesiol; 2015 Oct; 32(10):663-5. PubMed ID: 26322661
    [No Abstract]   [Full Text] [Related]  

  • 6. [Rocuronium used in rapid sequence intubation and reversal with sugammadex in a patient with myasthenia gravis].
    Illodo Miramontes G; Doniz Campos M; Filgueira Garrido P; Vázquez Martínez A
    Rev Esp Anestesiol Reanim; 2011 Dec; 58(10):626-7. PubMed ID: 22263415
    [No Abstract]   [Full Text] [Related]  

  • 7. [Sugammadex--a new agent for reversal of neuromuscular blockade].
    Claudius C; Gätke MR
    Ugeskr Laeger; 2009 Mar; 171(13):1091. PubMed ID: 19321086
    [No Abstract]   [Full Text] [Related]  

  • 8. Prolonged neuromuscular paralysis following rapid-sequence intubation with succinylcholine.
    Kaufman SE; Donnell RW; Aiken DC; Magee C
    Ann Pharmacother; 2011 Apr; 45(4):e21. PubMed ID: 21427295
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuromuscular blockade and outcome in cardiac anesthesia.
    Hemmerling TM; Zaouter C
    Ann Card Anaesth; 2010; 13(3):189-91. PubMed ID: 20826958
    [No Abstract]   [Full Text] [Related]  

  • 10. A randomized simultaneous comparison of acceleromyography with a peripheral nerve stimulator for assessing reversal of rocuronium-induced neuromuscular blockade with sugammadex.
    Drobnik L; Sparr HJ; Thörn SE; Khuenl-Brady KS; Rietbergen H; Prins ME; Ullman J
    Eur J Anaesthesiol; 2010 Oct; 27(10):866-73. PubMed ID: 20523215
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sugammadex reversal of rocuronium-induced neuromuscular blockade: a comparison with neostigmine-glycopyrrolate and edrophonium-atropine.
    Sacan O; White PF; Tufanogullari B; Klein K
    Anesth Analg; 2007 Mar; 104(3):569-74. PubMed ID: 17312210
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Case report: sugammadex used to successfully reverse vecuronium-induced neuromuscular blockade in a 7-month-old infant.
    Buchanan CC; O'Donnell AM
    Paediatr Anaesth; 2011 Oct; 21(10):1077-8. PubMed ID: 21981096
    [No Abstract]   [Full Text] [Related]  

  • 13. [Monitoring of neuromuscular block and prevention of residual paralysis].
    Fuchs-Buder T; Meistelman C
    Ann Fr Anesth Reanim; 2009 Sep; 28 Suppl 2():S46-50. PubMed ID: 19887277
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The use of sugammadex in a patient with myasthenia gravis].
    Challan Belval A; Tramoni G; Vedrinne JM; Olagne E; Vigneron M
    Ann Fr Anesth Reanim; 2012 Jun; 31(6):569-70. PubMed ID: 22677058
    [No Abstract]   [Full Text] [Related]  

  • 15. Pharmacologic recipes for tracheal intubation in the PICU: what's on the menu?
    Kudchadkar SR; Shaffner DH
    Pediatr Crit Care Med; 2015 Mar; 16(3):290-2. PubMed ID: 25738927
    [No Abstract]   [Full Text] [Related]  

  • 16. Reversal of rocuronium-induced neuromuscular blockade with sugammadex compared with neostigmine during sevoflurane anaesthesia: results of a randomised, controlled trial.
    Blobner M; Eriksson LI; Scholz J; Motsch J; Della Rocca G; Prins ME
    Eur J Anaesthesiol; 2010 Oct; 27(10):874-81. PubMed ID: 20683334
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sugammadex in anesthesia practice.
    Duvaldestin P; Plaud B
    Expert Opin Pharmacother; 2010 Nov; 11(16):2759-71. PubMed ID: 20977408
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Sugammadex: a new approach to muscle relaxation and its reversal].
    Duvaldestin P
    Ann Fr Anesth Reanim; 2009 Sep; 28 Suppl 2():S39-40. PubMed ID: 19887275
    [No Abstract]   [Full Text] [Related]  

  • 19. Sugammadex: the first selective binding reversal agent for neuromuscular block.
    Kovac AL
    J Clin Anesth; 2009 Sep; 21(6):444-53. PubMed ID: 19833281
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of residual neuromuscular blockade on the speed of reversal with sugammadex.
    White PF; Tufanogullari B; Sacan O; Pavlin EG; Viegas OJ; Minkowitz HS; Hudson ME
    Anesth Analg; 2009 Mar; 108(3):846-51. PubMed ID: 19224792
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.